Unresectable Triple-Negative Breast Carcinoma trials recruiting in Missouri

Fewer than 3 recruiting trials found.

All Unresectable Triple-Negative Breast Carcinoma trials nationally

Cities in Missouri

Recruiting trials in Missouri

• Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
  NCT07137416 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis